Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma Of Esophagus × Immune Checkpoint Inhibitors × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 2 Solid Cancers 2 Melanoma 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcopenia 1 SCLC 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Immune-Related Adverse Events 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

Fluorouracil 9 Oxaliplatin 8 Nivolumab 8 Leucovorin 7 Capecitabine 7 pembrolizumab 3 Trastuzumab 3 Specimen Handling 3 Paclitaxel 3 Cisplatin 3 zimberelimab 2 zanidatamab 2 dehydroftorafur 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Docetaxel 2 Biopsy 2 zolbetuximab 1 tucatinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 toripalimab 1 tislelizumab 1 quemliclustat 1 obeticholic acid 1 durvalumab 1 Taxes 1 Ramucirumab 1 Radiotherapy 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡